Awarded
Bleeding Disorders including Haemophilia B
£250,000,000
NHS EnglandPfizer Ltd
goods
Contract Details
- Tender Value
- £250,000,000
- Stage
- Awarded
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
Related Contracts
From This Buyer
- NHS England Bowel Cancer Screening Programme Managed Service
£210,462,766 ·
- Mural (Whiteboard) Enterprise Licenses 2026
£59,030 ·
- Cabinet Office Media Monitoring Unit
£14,000 ·
- PAS Silverlink Reprocurement 2026
£59,030 ·
From This Supplier
In This Category
Ref: b8e3e14d-0764-46e5-9863-3ae0473aa2e0-556027 · Sourced from Contracts Finder
View source notice